Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry Journal Article


Authors: Zeglis, B. M.; Davis, C. B.; Aggeler, R.; Kang, H. C.; Chen, A.; Agnew, B. J.; Lewis, J. S.
Article Title: Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry
Abstract: An enzyme- and click chemistry-mediated methodology for the site-selective radiolabeling of antibodies on the heavy chain glycans has been developed and validated. To this end, a model system based on the prostate specific membrane antigen-targeting antibody J591, the positron-emitting radiometal 89Zr, and the chelator desferrioxamine has been employed. The methodology consists of four steps: (1) the removal of sugars on the heavy chain region of the antibody to expose terminal N-acetylglucosamine residues; (2) the incorporation of azide-modified N-acetylgalactosamine monosaccharides into the glycans of the antibody; (3) the catalyst-free click conjugation of desferrioxamine-modified dibenzocyclooctynes to the azide-bearing sugars; and (4) the radiolabeling of the chelator-modified antibody with 89Zr. The site-selective labeling methodology has proven facile, reproducible, and robust, producing 89Zr-labeled radioimmunoconjguates that display high stability and immunoreactivity in vitro (>95%) in addition to highly selective tumor uptake (67.5 ± 5.0%ID/g) and tumor-to-background contrast in athymic nude mice bearing PSMA-expressing subcutaneous LNCaP xenografts. Ultimately, this strategy could play a critical role in the development of novel well-defined and highly immunoreactive radioimmunoconjugates for both the laboratory and clinic. © 2013 American Chemical Society.
Keywords: human cell; nonhuman; mouse; animal experiment; animal model; in vitro study; immunoreactivity; monoclonal antibody j591; isotope labeling; xenograft; zirconium; deferoxamine; click chemistry; glycan; n acetylglucosamine; azide; n acetylgalactosamine; heavy chain
Journal Title: Bioconjugate Chemistry
Volume: 24
Issue: 6
ISSN: 1043-1802
Publisher: American Chemical Society  
Date Published: 2013-06-19
Start Page: 1057
End Page: 1067
Language: English
DOI: 10.1021/bc400122c
PROVIDER: scopus
PMCID: PMC3714844
PUBMED: 23688208
DOI/URL:
Notes: --- - "Export Date: 1 August 2013" - "CODEN: BCCHE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Zeglis
    118 Zeglis
  2. Jason S Lewis
    456 Lewis
  3. Charles Braxton Davis
    4 Davis